Research

Balancing the risks and benefits of prescription drugs

The depiction of Judgment Day on the façade of the Cathedral of Notre Dame in Paris shows an angel weighing the good and evil of souls to determine where they should go. Hanging on one side are devils tilting the scale in the wrong direction. In making decisions about treating neurologic illnesses, physicians and their patients weigh risks and benefits of any treatment. For us, the devil is in the details of those risks and … Read More

Do you remember New Year’s Eve?

Hazy memories are a common post-party scenario on New Year’s Day, where the night before the crowd was alive with noise makers, silly hats and, for some, many different types of alcoholic beverages. Indeed, New Year’s Eve parties are nearly synonymous with alcohol consumption. And while many partygoers recognize that they will be drinking more than their normal amount of alcohol and make plans to get to and from a party safely, there also is … Read More

Amyloid fighting — is it the wrong Alzheimer’s fight?

A few months ago, experts were talking about the next generation of “disease-modifying” drugs that were expected to help treat Alzheimer’s disease by attacking amyloid plaque in the brain. In fact, they were arguing that any newly written treatment guidelines were likely to be quickly outdated by the advent of new, powerful drugs. Drug companies were also optimistic, developing all kinds of “anti-amyloid” drugs that were expected to fundamentally alter the course of the disease. “Amyloid” … Read More

OHSU Brain Institute Profile image

OHSU Brain Institute

We are a national leader in brain disease treatment and research.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.